Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Cervix carcinoma recurrent: Which Medications Are Safest? (51 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

51 medications are used for Cervix carcinoma recurrent, with 434 combined adverse event reports. The most reported drugs for Cervix carcinoma recurrent are PACLITAXEL and BEVACIZUMAB.

434
Total Reports
51
Drugs Used

All Medications for Cervix carcinoma recurrent Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
PACLITAXEL PACLITAXEL PACLITAXEL 133 12,030 31,638 15.6%
BEVACIZUMAB JOBEVNE 116 17,498 23,114 22.4%
CARBOPLATIN Carboplatin 116 12,544 35,869 14.9%
PEMBROLIZUMAB KEYTRUDA 110 15,543 35,472 18.6%
CEMIPLIMAB-RWLC - 72 323 441 20.8%
TISOTUMAB VEDOTIN-TFTV - 47 39 76 7.0%
CISPLATIN CISplatin 32 8,387 17,469 17.7%
ATEZOLIZUMAB Tecentriq Hybreza 21 8,520 15,094 25.3%
TISOTUMAB VEDOTIN TIVDAK 14 16 101 9.6%
GEMCITABINE Gemcitabine 12 5,142 12,268 16.4%
IRINOTECAN Irinotecan Hydrochloride 12 4,530 10,384 16.2%
TOPOTECAN HYCAMTIN 10 773 1,213 21.9%
TOPOTECAN\TOPOTECAN - 8 150 78 29.4%
VELIPARIB - 8 43 222 11.0%
NIVOLUMAB OPDIVO 6 23,086 36,530 26.3%
NEDAPLATIN - 5 94 282 12.7%

View all 51 drugs →

Most Reported Drugs for Cervix carcinoma recurrent

#1 most reported
#2 most reported
#3 most reported